Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-02-22 @ 3:04 AM
Study NCT ID:
NCT02293005
Status:
COMPLETED
Last Update Posted:
2022-10-04
First Post:
2014-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma
Sponsor:
Organization: